Medicare Enrolled

Dr. Syed Abid, MD

Optician · St Petersburg, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
5000 PARK ST N STE 1017, St Petersburg, FL 33709
7273446569
In practice since 2005 (20 years)
NPI: 1013902006 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abid from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abid? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abid

Dr. Syed Abid is an optician in St Petersburg, FL, with 20 years in practice. Based on federal Medicare data, Dr. Abid performed 40,621 Medicare services across 1,189 unique beneficiaries.

Between the years covered by Open Payments, Dr. Abid received a total of $14,729 from 82 pharmaceutical and/or device companies across 749 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abid is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 2% volume in FL$ $14,729 industry payments

Medicare Practice Summary

Medicare Utilization ↗
40,621
Medicare services
Top 2% in FL for optician
1,189
Unique beneficiaries
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,031 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)19,380$0$1
Iron infusion (Injectafer)14,250$1$3
Epoetin alfa injection (Retacrit) for anemia3,283$5$17
Dexamethasone injection (steroid)870$0$1
Complete blood count (CBC) with differential460$8$23
Blood draw (venipuncture)458$8$18
Comprehensive metabolic blood panel212$10$32
Drug injection, under skin or into muscle193$11$34
Ferritin level test (iron stores)141$13$34
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less141$22$68
Lactate dehydrogenase (enzyme) level139$6$15
Magnesium level test139$7$17
Office visit, established patient (30-39 min)124$93$310
Iron level test120$6$16
Phosphate level test116$5$12
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less93$49$151
Administration of chemotherapy into vein, 1 hour or less73$100$307
Office visit, established patient (20-29 min)66$65$219
Injection, diphenhydramine hcl, up to 50 mg62$1$3
New patient office visit, complex (60-74 min)52$168$537
Vitamin B-12 level test51$15$38
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg47$1$4
Injection of additional new drug or substance into vein39$12$37
Immunoglobulin level test36$9$23
Folic acid level test25$14$37
Carcinoembryonic antigen (cea) protein level24$19$47
Initial hospital admission, high complexity14$139$427
Transferrin (iron binding protein) level13$12$32
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
83.4% high complexity
11.2% medium
5.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$14,729
Total received (2018-2024)
Avg $2,104/year across 7 years
Top 10% in FL for optician
82
Companies
749
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,329 (90.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,400 (9.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,140
2023
$3,277
2022
$2,509
2021
$1,688
2020
$1,613
2019
$1,539
2018
$964

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,556
E.R. Squibb & Sons, L.L.C.
$1,131
PFIZER INC.
$1,036
Merck Sharp & Dohme LLC
$697
AstraZeneca Pharmaceuticals LP
$641
Daiichi Sankyo Inc.
$608
Merck Sharp & Dohme Corporation
$531
Astellas Pharma US Inc
$518
Janssen Biotech, Inc.
$493
Exelixis Inc.
$483
Seagen Inc.
$462
Amgen Inc.
$452
Takeda Pharmaceuticals U.S.A., Inc.
$381
Incyte Corporation
$318
GlaxoSmithKline, LLC.
$310
Genentech USA, Inc.
$307
Lilly USA, LLC
$303
GENZYME CORPORATION
$292
Celgene Corporation
$283
Gilead Sciences, Inc.
$245
Kite Pharma, Inc.
$205
ABBVIE INC.
$194
Boehringer Ingelheim Pharmaceuticals, Inc.
$177
ARRAY BIOPHARMA INC
$168
Regeneron Healthcare Solutions, Inc.
$161
Seattle Genetics, Inc.
$156
BeiGene USA, Inc.
$152
Karyopharm Therapeutics Inc.
$144
TerSera Therapeutics LLC
$141
Stemline Therapeutics Inc.
$124
Pharmacyclics LLC, An AbbVie Company
$122
Ipsen Biopharmaceuticals, Inc
$118
Mirati Therapeutics, Inc.
$113
Celltrion USA Inc.
$112
PUMA BIOTECHNOLOGY, INC.
$104
Fennec Pharmaceuticals, Inc.
$99
Eisai Inc.
$81
AbbVie Inc.
$76
JAZZ PHARMACEUTICALS INC.
$64
Tempus AI, Inc
$60
AVEO Pharmaceuticals, Inc.
$55
Acrotech Biopharma LLC
$53
Genmab U.S., Inc.
$50
Bayer Healthcare Pharmaceuticals Inc.
$46
AMAG Pharmaceuticals, Inc.
$43
TAIHO ONCOLOGY, INC.
$41
CTI BioPharma Corp.
$39
Agios Pharmaceuticals, Inc.
$37
Partner Therapeutics, Inc.
$35
Foundation Medicine, Inc.
$35
Sumitomo Pharma America, Inc.
$34
Dova Pharmaceuticals
$32
Rigel Pharmaceuticals, Inc.
$30
Novo Nordisk Inc
$30
Janssen Pharmaceuticals, Inc
$29
EMD Serono, Inc.
$29
Verity Pharmaceuticals Inc.
$28
Heron Therapeutics, Inc.
$26
GE HealthCare
$26
RECORDATI_RARE_DISEASES_INC.
$23
AbbVie, Inc.
$23
Epizyme, Inc.,
$21
Array BioPharma Inc.
$21
MorphoSys, US Inc.
$21
Octapharma USA, Inc.
$20
Servier Pharmaceuticals LLC
$19
Teva Pharmaceuticals USA, Inc.
$19
Fresenius Kabi USA, LLC
$19
Blueprint Medicines Corporation
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Myovant Sciences Inc.
$18
Global Blood Therapeutics, Inc.
$18
EISAI INC.
$18
Sun Pharmaceutical Industries Inc.
$17
Taiho Oncology, Inc.
$17
Emmaus Medical, Inc.
$17
Amneal Pharmaceuticals LLC
$16
Kyowa Kirin, Inc.
$16
Inari Medical, Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$15
Organon LLC
$15
Puma Biotechnology, Inc.
$11
Top 3 companies account for 25.3% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALUNBRIG · AUGTYRO · AVASTIN · AYVAKIT · Avastin · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · CT THROMBECTOMY SYSTEM KIT · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELITEK · ELREXFIO · EMEND · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · EVENITY · EXKIVITY · Endari · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GENERAL VASCULAR INTERVENTION · GILOTRIF · Gazyva · HEMADY · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MARQIBO · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NINLARO · Neulasta · Novoeight · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Padcev · Pedmark · Perjeta · Phesgo · REBLOZYL · RETEVMO · Rezlidhia · SANDOSTATIN · SARCLISA · SOMATULINE DEPOT · SUSTOL · SUTENT · SYLVANT · Somatuline Depot · Stimufend · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Trelstar · Trodelvy · VARUBI · VEGZELMA · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for optician in FL.

Equivalent to $36 per 100 Medicare services performed
Looking for a optician in St Petersburg?
Compare opticians in the St Petersburg area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
430
Per 100K population
44.8
County median income
$70,293
Nearest hospital
HCA FLORIDA NORTHSIDE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Abid is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (low-engagement, top 10%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Abid experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Abid performed 19,380 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abid receive payments from pharmaceutical companies?
Yes. Dr. Abid received a total of $14,729 from 82 companies across 749 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abid's costs compare to other opticians in St Petersburg?
Dr. Abid's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abid) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →